Kolexia
Carrat Fabrice
Santé publique
Hôpital Saint-Antoine
Paris, France
401 Activités
26 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Grippe humaine Hépatite C chronique COVID-19 Hépatite B Cirrhose du foie Fibrose Hépatite chronique

Industries

Sanofi
3 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.
Scientific reports   05 mars 2024
Real-world economic burden of hepatitis C and impact of direct-acting antivirals in France: A nationwide claims data analysis.
Liver international : official journal of the International Association for the Study of the Liver   20 février 2024
SAPRIS-SERO: Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis - Serology
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   20 février 2024
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Impact of translation on biomedical information extraction: an experiment on real-life clinical notes.
JMIR medical informatics   10 janvier 2024
Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort).
Drug and alcohol review   22 décembre 2023
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
The Journal of infectious diseases   23 novembre 2023
Heart and systemic sclerosis-findings from a national cohort study.
Rheumatology (Oxford, England)   07 novembre 2023
Association of SARS-CoV-2 infection with physical activity domains and types.
Scientific reports   06 novembre 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.
Med (New York, N.Y.)   01 novembre 2023